Cosmos Pharmaceutical Corp banner

Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 6 135 JPY -1.19% Market Closed
Market Cap: ¥490.8B

Wall St Price Targets

Price Forecast
Based on 13 analysts

+30% Upside
from ¥6 135 today

Cosmos Pharmaceutical Corp (3349)’s 12-month stock price forecast through September 2027 has a consensus target of ¥7 956, implying 30% upside. The forecast is based on price targets from 13 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Cosmos Pharmaceutical Corp yet.

Cosmos Pharmaceutical Corp Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Cosmos Pharmaceutical Corp's stock price target?
Price Target
7 956 JPY

According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 7 956 JPY with a low forecast of 6 767 JPY and a high forecast of 10 500 JPY.

What is the Revenue forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 1 year is 15%.

What is the Pre-Tax Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 7%.

What is the Net Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.

Back to Top